VSee Health Inc. Receives Nasdaq Delisting Warning Over Minimum Bid Price and Reporting Noncompliance
Reuters
Sep 29
VSee Health Inc. Receives Nasdaq Delisting Warning Over Minimum Bid Price and Reporting Noncompliance
**VSee Health Inc. Receives Nasdaq Delisting Warning Over Listing Rule Violations** VSee Health Inc. announced it has received a deficiency letter from Nasdaq, warning that the company's stock has closed below the $1.00 minimum bid price requirement for 30 consecutive business days, in violation of Nasdaq Listing Rule 5550(a)(2). The company has until March 23, 2026, to regain compliance or face possible delisting. VSee Health is also non-compliant with other Nasdaq requirements, including timely SEC filings and minimum stockholders' equity. The company is working to address these issues but warns there is no guarantee of maintaining its listing. The Nasdaq notice does not immediately affect trading of VSee Health's stock.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-25-001289), on September 29, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.